Form 8-K - Current report:
SEC Accession No. 0001493152-24-042867
Filing Date
2024-10-29
Accepted
2024-10-29 16:01:19
Documents
13
Period of Report
2024-10-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48522
  Complete submission text file 0001493152-24-042867.txt   229615

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE fblg-20241025.xsd EX-101.SCH 3033
3 XBRL LABEL FILE fblg-20241025_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE fblg-20241025_pre.xml EX-101.PRE 24177
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3810
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41934 | Film No.: 241405614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)